TrialBritish journal of cancer2003

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study.

G J S Rustin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.